Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B) Peptide

PLA2G4B Reactivité: Mammifères Hôte: Synthetic BP, WB, IHC
N° du produit ABIN939674
  • Antigène Tous les produits PLA2G4B
    PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
    Type de proteíne
    Synthetic
    Origine
    Mammifères
    Source
    • 5
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
    Séquence
    KDHYENLYCV VSGEKHFLFH PPSDRPFIPY ELYTPATYQL TEEGTFKVVD
    Attributs du produit
    A synthetic peptide for use as a blocking control in assays to test for specificity of PLA2 G2 antibody,
    Alternative Names: PLA2G4B control peptide, PLA2G4B antibody Blocking Peptide, Anti-PLA2G4B Blocking Peptide, phospholipase A2, group IVB, cytosolic Blocking Peptide, FLJ42498 Blocking Peptide, HsT16992 Blocking Peptide, cPLA2-beta Blocking Peptide, PLA2G4B, PLAG4B-2, PLAG4B 2, PLAG4B-2 Blocking Peptide, PLAG4B 2 Blocking Peptide
  • Indications d'application
    Optimal conditions should be determined by the investigator
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
    Buffer
    PBS
    Conseil sur la manipulation
    Avoid repeated freeze/thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20 °C long term.
  • Antigène
    PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
    Synonymes
    HsT16992 Peptide, cPLA2-beta Peptide, A030011C02Rik Peptide, Gm1013 Peptide, phospholipase A2 group IVB Peptide, phospholipase A2, group IVB (cytosolic) Peptide, PLA2G4B Peptide, Pla2g4b Peptide
    Sujet
    This gene transcribes naturally-occurring mRNAs that are co-transcribed products of the neighboring JMJD7 and PLA2G4B genes. Incompletely processed read-through transcripts from these two loci are abundantly expressed in most tissues, but the function of the predicted protein product has not yet been determined. Alternative splicing of this gene results in different transcript variants, some of which are candidates for nonsense-mediated decay (NMD).
    Poids moléculaire
    114 kDa
Vous êtes ici:
Support technique